Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency

被引:116
作者
Lembo, G
Rockman, HA
Hunter, JJ
Steinmetz, H
Koch, WJ
Ma, L
Prinz, MP
Ross, J
Chien, KR
PowellBraxton, L
机构
[1] UNIV CALIF SAN DIEGO, DEPT MED, 0613C, AMER HEART ASSOC BUGHER FDN CTR MOL BIOL, LA JOLLA, CA 92093 USA
[2] UNIV CALIF SAN DIEGO, CTR MOL GENET, LA JOLLA, CA 92093 USA
[3] UNIV CALIF SAN DIEGO, DEPT PHARMACOL, LA JOLLA, CA 92093 USA
[4] DUKE UNIV, DEPT SURG, DURHAM, NC USA
[5] GENENTECH INC, S SAN FRANCISCO, CA 94080 USA
关键词
insulin-like growth factor I; mutagenesis; site-directed; myocardial contraction; hypertension; adrenergic receptors; beta receptors;
D O I
10.1172/JCI119086
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To circumvent the embryonic lethality of a complete deficiency in insulin-like growth factor 1 (IGF-1), we generated mice homozygous for a site-specific insertional event that created a mutant IGF-1 allele (igf1(m)). These mice have IGF-1 levels 30% of wild type yet survive to adulthood, thereby allowing physiological analysis of the phenotype. Miniaturized catheterization technology revealed elevated conscious blood pressure in IGF-1(m/m) mice, and measurements of left ventricular contractility were increased. Adenylyl cyclase activity was enhanced in IGF-1(m/m) hearts, without an increase in beta-adrenergic receptor density, suggesting that crosstalk between IGF-1 and beta-adrenergic signaling pathways may mediate the increased contractility. The hypertrophic response of the left ventricular myocardium in response to aortic constriction, however, was preserved in IGF-1(m/m) mice. We conclude that chronic alterations in IGF-1 levels can selectively modulate blood pressure and left ventricular function, while not affecting adaptive myocardial hypertrophy in vivo.
引用
收藏
页码:2648 / 2655
页数:8
相关论文
共 46 条
  • [1] THE VASODILATOR ACTION OF INSULIN - IMPLICATIONS FOR THE INSULIN HYPOTHESIS OF HYPERTENSION
    ANDERSON, EA
    MARK, AL
    [J]. HYPERTENSION, 1993, 21 (02) : 136 - 141
  • [2] BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
  • [3] PHYSIOLOGICAL-EFFECTS OF INVERSE AGONISTS IN TRANSGENIC MICE WITH MYOCARDIAL OVEREXPRESSION OF THE BETA(2)-ADRENOCEPTOR
    BOND, RA
    LEFF, P
    JOHNSON, TD
    MILANO, CA
    ROCKMAN, HA
    MCMINN, TR
    APPARSUNDARAM, S
    HYEK, MF
    KENAKIN, TP
    ALLEN, LF
    LEFKOWITZ, RJ
    [J]. NATURE, 1995, 374 (6519) : 272 - 276
  • [4] ADRENOCEPTOR-MEDIATED CARDIAC AND VASCULAR-RESPONSES IN GENETICALLY GROWTH HORMONE-DEFICIENT RATS
    BROWN, L
    WYSE, B
    SERNIA, C
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (11) : 2223 - 2229
  • [5] MOLECULAR ADVANCES IN CARDIOVASCULAR BIOLOGY
    CHIEN, KR
    [J]. SCIENCE, 1993, 260 (5110) : 916 - 917
  • [6] CARDIAC-MUSCLE DISEASES IN GENETICALLY-ENGINEERED MICE - EVOLUTION OF MOLECULAR PHYSIOLOGY
    CHIEN, KR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (03): : H755 - H766
  • [7] LINKAGE OF 11-BETA-HYDROXYLASE MUTATIONS WITH ALTERED STEROID-BIOSYNTHESIS AND BLOOD-PRESSURE IN THE DAHL RAT
    CICILA, GT
    RAPP, JP
    WANG, JM
    STLEZIN, E
    NG, SC
    KURTZ, TW
    [J]. NATURE GENETICS, 1993, 3 (04) : 346 - 353
  • [8] Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat - A combined in vivo and in vitro evaluation
    Cittadini, A
    Stromer, H
    Katz, SE
    Clark, R
    Moses, AC
    Morgan, JP
    Douglas, PS
    [J]. CIRCULATION, 1996, 93 (04) : 800 - 809
  • [9] RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR-I INCREASES FOREARM BLOOD-FLOW
    COPELAND, KC
    NAIR, KS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (01) : 230 - 232
  • [10] CZERWINSKI SM, 1993, MED SCI SPORT EXER, V25, P495